Expectations trend
FY2028 · fiscal year ending 2028-09-30 · fmp
Amtech Systems Inc (ASYS)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
$11.09-10.24%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.68 → 0.58 EPS · FY ending Sep 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ASYS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit rises to about $9.77M in Q2 2026 | A primary condition in Amtech Systems Inc's published investment case. The stated target is ~$9.77M. | Improving | Gross profit falls below $8.5M in 2026-Q2 | Gross profit: $11.193M FY2026-Q3; GAAP. Published target: ~$9.77M. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Aug 5, 202611,193,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk growth business, not yet a proven durable compounder, because it remains loss-making despite recent improvement. The long-term thesis is intact: recent financial performance is strong, and management’s growth and profitability priorities are on track.
The valuation is expensive versus peers, and its valuation measure has risen recently. The priced-in assessment is tagged as justified, with low fragility, but the negative expectations gap suggests the market may be assuming more than the current fundamentals support.
Near term, revenue growth and profitability have improved, with AI-related demand supporting the latest reported growth and operating income rising. The next call’s guidance is a key risk, while management’s new M&A priority has not yet shown delivery; the CEO transition also adds uncertainty.
Over the next few quarters, the thesis hinges on sustaining AI-related demand and converting revenue growth into stronger profitability. Guidance cuts would weaken the case, while easing rates or stabilization among major technology companies could support the sector backdrop, though neither is assured.
For the 1–3 year view, ASYS has a credible growth and operating-improvement story, but its loss-making position, high risk, and expensive peer valuation make continued execution central to the thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Amtech Systems Inc's published investment case. The stated target is ~$21.5M. |
| Intact |
| Revenue falls below $20M in 2026-Q2 |
Revenue: $22.383M FY2026-Q3; GAAP. Published target: ~$21.5M. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Aug 5, 202622,383,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful M&A to strengthen market position | A supporting condition in Amtech Systems Inc's published investment case. The stated target is Complete strategic deals that add value in 2026. | Intact | No meaningful M&A deals completed by end of 2026 | 1 M&A deal completed vs 0 required Company entered a Material Definitive Agreement on June 1, 2026, confirming M&A activity. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.68 → $0.58 · observed estimates
$0.11B → $0.11B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-01 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-02 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-03 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-04 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-05 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-06 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-07 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-08 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-09 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-10 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-11 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-12 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-13 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-14 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-15 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-16 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-17 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-18 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-19 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-20 | $0.68 | $108,008,000 | 1 / 1 |
| 2026-10-21 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-22 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-23 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-24 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-25 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-26 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-27 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-28 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-29 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-30 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-10-31 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-11-01 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-11-02 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-11-03 | $0.58 | $108,017,000 | 1 / 1 |
| 2026-11-04 | $0.58 | $108,017,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.